A Randomized, Double-blind, Placebo-controlled, Multicenter Study of a Single Dose of Inclacumab to Reduce Re-admission in Participants with Sickle Cell Disease and Recurrent Vaso-occlusive Crises
2022-11-21
عنوان الدراسة
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of a Single Dose of Inclacumab to Reduce Re-admission in Participants with Sickle Cell Disease and Recurrent Vaso-occlusive Crises
داعم الدراسة
Global Blood Therapeutics (GBT)
دواء الدراسة
Inclacumab
رقم بروتوكول الدراسة
GBT2104-132
حالة الدراسة
Completed
موقع الدراسة
Prince Mohammad Bin Naser Hospital, Jizan, Saudi Arabi
مرحلة الدراسة
3
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.